
AtriCure (ATRC) Stock Forecast & Price Target
AtriCure (ATRC) Analyst Ratings
Bulls say
AtriCure is positioned for success in the medical technology industry with a strong product line, focus on innovation, and expanding global presence, making it a promising investment opportunity. Additionally, its strong financials and recent launch of new products suggest the potential for continued revenue and earnings growth in the future. Overall, AtriCure appears to be well-positioned for long-term success and has a positive outlook.
Bears say
AtriCure is a medical innovator with a negative outlook due to its potential competition in the cardiac surgery market and lower expected sales in the back half of the year. Additionally, their quality measure update could result in less revenue than previously expected. These fundamental reasons, along with a revision in their 2026 outlook, lead to a pessimistic view of the company's stock.
This aggregate rating is based on analysts' research of AtriCure and is not a guaranteed prediction by Public.com or investment advice.
AtriCure (ATRC) Analyst Forecast & Price Prediction
Start investing in AtriCure (ATRC)
Order type
Buy in
Order amount
Est. shares
0 shares